Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
08/2013
08/07/2013CN102056902B Imidazolidine derivatives
08/07/2013CN101208352B Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
08/06/2013US8501937 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
08/06/2013US8501782 Piperidinyl derivatives as modulators of chemokine receptor activity
08/06/2013US8501779 Polymorphs of donepezil salts, preparation methods and uses thereof
08/06/2013US8501778 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent
08/06/2013US8501777 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission
08/06/2013US8501775 Anthelmintics for preventing parasitic infections in humans and animals
08/06/2013US8501773 4-fluoro-piperidine T-type calcium channel antagonists
08/06/2013US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/06/2013US8501658 Enantioselective reactions catalyzed by chiral triazolium salts
08/06/2013CA2690686C Amine compound and pharmaceutical use thereof
08/06/2013CA2609388C Novel piperidine derivative
08/06/2013CA2563180C Non-nucleoside reverse transcriptase inhibitors
08/01/2013WO2013112323A1 Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors
08/01/2013WO2013110135A1 Heterocyclic compounds and methods for their use
08/01/2013WO2012006474A3 Compounds and methods for inhibiting phosphate transport
08/01/2013US20130197031 Deuterated analogs of pridopidine useful as dopaminergic stabilizers
08/01/2013US20130196992 1',3'-disubstituted-4-pheny-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
08/01/2013US20130196978 Alkaloid aminoester derivatives and medicinal composition thereof
07/2013
07/31/2013EP2620429A1 Hydroxylamine compounds and methods of their use
07/31/2013EP2620428A1 Asymmetric auxiliary group
07/31/2013EP2619180A1 5-ht2b receptor antagonists
07/31/2013EP2619178A1 Substituted benzamide compounds
07/31/2013CN103224474A Synthesis of tetracyclines and analogues thereof
07/31/2013CN103224465A 2,2,6,6,-tetramethyl-4-piperidone continuous synthesis method
07/31/2013CN103224464A Cyclohexene derivative or its pharmaceutically acceptable salt and application thereof
07/31/2013CN102143948B Process for preparing (s)-(-)-felodipine
07/31/2013CN101863883B Piperidone azine compound with activity of resisting leukemia K562 cell proliferation and preparation method thereof
07/31/2013CN101460462B Spirocyclic nitriles as protease inhibitors
07/30/2013US8497380 Substituted acetophenones useful as PDE4 inhibitors
07/30/2013US8497286 Organic compounds
07/30/2013CA2479764C Hemiasterlin derivatives and uses thereof
07/25/2013WO2013107336A1 Therapeutic uses
07/25/2013WO2013050987A9 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors
07/25/2013US20130190502 Acylation reaction of hydroxyl group
07/25/2013US20130190488 Apoptosis promoters
07/25/2013US20130190352 Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
07/25/2013US20130190288 Benzyl sulfonamide derivatives as rorc modulators
07/24/2013CN103221392A Bridged spiro[2.4]heptane ester derivatives
07/24/2013CN103221113A Amine-containing absorption medium, process and apparatus for absorption of acidic gases from gas mixtures
07/24/2013CN103214467A 5-[[4-[(2, 3-dimethyl-2H-indazole-6-yl) methylamino]-2-pyrimidyl] amino]-2-methyl-benzsulfamide derivative and preparation method and applications thereof
07/24/2013CN103214460A Chemical compounds
07/24/2013CN103214409A Synthesis of tetracyclines and analogues thereof
07/24/2013CN102249987B Combretastatin compound and preparation method and application thereof
07/24/2013CN102112439B 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
07/24/2013CN101896459B Anthelmintic agents and their use
07/24/2013CN101405264B Piperidinyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
07/23/2013US8492550 Hydroxyalkanyl amides as modulators of chemokine receptor activity
07/23/2013US8492437 4-substituted phenoxyphenylacetic acid derivatives
07/23/2013US8492111 Arylalkylamine compound and process for preparing the same
07/23/2013US8491669 Cationic 4-aminopyridine, dye composition comprising a cationic 4-aminopyridine, processes therefor and uses thereof
07/18/2013WO2013105753A1 Substituted piperidine derivatives and methods for preparing the same
07/18/2013US20130184278 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/18/2013US20130184262 Diaminocyclohexane compounds and uses thereof
07/18/2013US20130184257 Piperidinyl-substituted lactams as gpr119 modulators
07/18/2013US20130181107 Furnace mount and method of installation
07/17/2013EP2615084A1 Prostaglandin d synthase inhibitory piperidine compounds
07/17/2013CN103204801A Synthesis method for N-Boc-3-piperidone
07/17/2013CN103204800A Method for extracting high purity 1-deoxynojirimycin
07/17/2013CN103204799A (2S,3R)-1-substituted benzyl-2-allyl-3-hydroxypiperidine and preparation method thereof
07/17/2013CN103204787A Mulin acetate comprising substituted squaric acid, and application thereof
07/17/2013CN102076663B Piperidinyl derivative as modulator of chemokine receptor activity
07/17/2013CN101835750B Cyclopropyl amide derivatives '978
07/17/2013CN101663270B Quaternary ammonium compounds useful as muscarinic receptor antagonists
07/17/2013CN101528695B Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
07/16/2013US8487109 Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
07/16/2013US8487108 Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors
07/16/2013US8486940 Inhibitors
07/16/2013CA2583983C Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
07/16/2013CA2537257C Fexofenadine polymorphs and processes of preparing the same
07/16/2013CA2534094C Glycosidase inhibitors and methods of synthesizing same
07/16/2013CA2485592C Anti tubercular drug: compositions and methods
07/11/2013US20130178612 Chiral auxiliaries
07/11/2013US20130178494 Phenyl n-mustard linked to dna-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents
07/11/2013US20130178444 Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity
07/10/2013EP2611776A2 Production method of intermediate compound for synthesizing medicament
07/10/2013EP2611759A1 Deuterated analogs of pridopidine useful as dopaminergic stabilizers
07/10/2013CN103201264A Sterically hindered amines
07/10/2013CN103201258A Amyloid binding agents
07/10/2013CN103193771A New use of drug of chain amide CCR5 (chemokine receptor) receptor antagonist
07/10/2013CN103193700A Benzenesulfonic acid levamlodipine crystal and pharmaceutical composition containing same
07/10/2013CN103193699A Novel method for preparing prucalopride intermediate
07/10/2013CN103193698A Preparation method of N-triacetic acid (1,2,2,6,6-pentamethyl-4-piperidyl) ester as hindered amine light stabilizer
07/10/2013CN102079744B Deuterated achiral crizotinib and derivatives, preparation method and application thereof
07/10/2013CN102060749B Preparation method of 2-cyan-7-aza-spiro[3,5]nonane derivative
07/09/2013US8481743 Phenylpropionamide compounds and the use thereof
07/09/2013US8481726 Process for the preparation of sterically hindered nitroxyl ethers
07/09/2013US8481527 Benzamide derivatives as bradykinin antagonists
07/09/2013CA2671749C Bicyclic compounds and uses as antidiabetics
07/04/2013WO2013097947A1 Pipecolate-sulfonamides for treatment of psychiatric disorders
07/04/2013US20130172562 Process for the preparation of a single enantiomer of 3-aminopiperidine dihydrochloride
07/04/2013US20130172388 Novel cannabinoid receptor 2 (cb2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases
07/04/2013US20130172386 5-ht2b receptor antagonists
07/04/2013US20130172385 Anthelmintics for preventing parasitic infections in humans and animals
07/04/2013US20130172347 C5ar antagonists
07/04/2013US20130172319 Alpha-AminoCycloLactam Ligands for G-Protein Coupled Receptors, and Methods of Using Same
07/04/2013US20130172318 Anti-inflammatory agents
07/04/2013US20130172315 Substituted anilines as ccr(4) antagonists
07/04/2013US20130172301 Biphenyl compounds useful as muscarinic receptor antagonists
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 380